These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7720238)

  • 21. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity.
    Strandberg K; Lethagen S; Andersson K; Carlson M; Hillarp A
    Clin Appl Thromb Hemost; 2006 Jan; 12(1):61-7. PubMed ID: 16444436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factor.
    Miller CH; Platt SJ; Daniele C; Kaczor D
    Thromb Haemost; 2002 Jul; 88(1):56-9. PubMed ID: 12152679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels.
    Federici AB; Canciani MT; Forza I; Mannucci PM; Marchese P; Ware J; Ruggeri ZM
    Haematologica; 2004 Jan; 89(1):77-85. PubMed ID: 14754609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease.
    De Vleeschauwer A; Devreese K
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):353-8. PubMed ID: 16788311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rapid, automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Willebrand disease.
    Bowyer AE; Shepherd F; Kitchen S; Makris M
    Thromb Res; 2011 Apr; 127(4):341-4. PubMed ID: 21186048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid assay for von Willebrand factor.
    Zaleski A; Olson JD
    Thromb Res; 1988 Aug; 51(4):462-8. PubMed ID: 3263714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis or Exclusion of von Willebrand Disease Using Laboratory Testing.
    Favaloro EJ
    Methods Mol Biol; 2017; 1646():391-402. PubMed ID: 28804843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.
    Favaloro EJ
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):553-64. PubMed ID: 21885953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of an automated platelet-based assay of ristocetin cofactor activity.
    Lawrie AS; Mackie IJ; Machin SJ; Peyvandi F
    Haemophilia; 2011 Mar; 17(2):252-6. PubMed ID: 21070498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method.
    Stufano F; Baronciani L; Mane-Padros D; Cozzi G; Faraudo S; Peyvandi F
    Haemophilia; 2018 Jan; 24(1):156-161. PubMed ID: 29168270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.